The results from the reactive oxygen species (ROS) assay offered further validation, demonstrating a statistically highly significant 2.6-fold augmentation in ROS production in the group treated with the combination of APMP and radiotherapy compared to radiotherapy treatment alone (Fig. 3 h-i).
← all excerpts
MXene-based nanosheet for enhanced glioma therapy via photonic hyperthermia to boost the abscopal effect of radioimmunotherapy.
1
—
—